1. Home
  2. MFA vs AVDL Comparison

MFA vs AVDL Comparison

Compare MFA & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFA Financial Inc.

MFA

MFA Financial Inc.

HOLD

Current Price

$9.71

Market Cap

976.0M

Sector

Real Estate

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.59

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFA
AVDL
Founded
1997
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
976.0M
2.1B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
MFA
AVDL
Price
$9.71
$21.59
Analyst Decision
Buy
Buy
Analyst Count
7
9
Target Price
$10.96
$18.38
AVG Volume (30 Days)
1.0M
1.6M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
14.83%
N/A
EPS Growth
N/A
N/A
EPS
0.86
N/A
Revenue
$279,011,000.00
$248,517,000.00
Revenue This Year
N/A
$65.47
Revenue Next Year
$3.18
$30.88
P/E Ratio
$11.30
N/A
Revenue Growth
N/A
79.88
52 Week Low
$7.85
$6.38
52 Week High
$11.08
$23.57

Technical Indicators

Market Signals
Indicator
MFA
AVDL
Relative Strength Index (RSI) 55.94 59.89
Support Level $9.66 $21.36
Resistance Level $9.88 $21.67
Average True Range (ATR) 0.15 0.12
MACD 0.00 -0.11
Stochastic Oscillator 56.98 67.09

Price Performance

Historical Comparison
MFA
AVDL

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: